Pfizer Inc (PFE.N)
|Market Cap (Mil.):||$186,451.50|
|Shares Outstanding (Mil.):||6,372.23|
LONDON - AstraZeneca raised its sales and earnings forecasts for the year on Thursday, showing resilience after seeing off a $118 billion takeover approach from rival Pfizer two months ago.
* Now assuming generic Nexium in U.S. from Oct. 1 (Adds CEO comments from conference call, further analyst comment)
July 31 - AstraZeneca PLC CEO Pascal Soriot told reporters: * CEO says can't comment on Pfizer, says November 18 investor day will focus on
EDINBURGH, July 31 - British blue chip shares rose on Thursday, boosted by better than expected earnings reports, with the oil and gas sector lifted by rising profits.
LONDON, July 31 - AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach from rival drugmaker Pfizer two months ago.
- Pfizer Inc agreed on Wednesday to buy Baxter International Inc's vaccines unit and a part of a production facility for $635 million.
July 30 - Pfizer Inc agreed on Wednesday to buy Baxter International Inc's vaccines unit and a part of a production facility for $635 million.
(Corrects third paragraph to " ... outside the United States" from " ... in the United States")
- Pfizer Inc , which in May abandoned its $118 billion bid for AstraZeneca Plc , on Tuesday left investors guessing whether it would renew its pursuit of its British rival, but said it was considering other deals. | Video
* Merck up as results beat expectations, but Pfizer slips
|Johnson & Johnson (JNJ.N)||$100.51||-1.79|
|Novartis AG (NOVN.VX)||CHF79.55||-0.80|
|Merck & Co., Inc. (MRK.N)||$57.03||-1.05|
|Roche Holding Ltd. (ROG.VX)||CHF264.70||-2.00|
|Abbott Laboratories (ABT.N)||$42.11||-0.75|
|Bayer AG (BAYGn.DE)||€98.92||-2.08|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€78.62||+1.73|
|AstraZeneca plc (AZN.L)||4,344.50p||-13.00|
|GlaxoSmithKline plc (GSK.L)||1,436.50p||+11.50|
Earnings vs. Estimates
Analyst Research Reports
Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
"The Economy Matters" Report for PFE: the economy's impact on PFE's price and risk, featuring the powerful Economic Climate Rating
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.